Stock Fundamentals

Company Information

▼
Company Name
Danaher Corporation
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NYSE
ISIN: US2358511028
CIK: 0000313616
CUSIP: 235851110
Currency: USD
Full Time Employees: 58,000
Phone: 202 828 0850
Website: https://www.danaher.com
Fiscal Year End: December
IPO Date: Jan 05, 1979
Description:

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Address:

2200 Pennsylvania Avenue N.W., Washington, DC, United States, 20037-1701

Directors & Officers

▼
Name Title Year Born
Mr. Steven M. Rales Co-Founder & Chairman 1951
Mr. Rainer M. Blair President, CEO & Director 1964
Mr. Mitchell P. Rales Co-Founder & Director 1957
Mr. Matthew R. McGrew Executive Vice President 1972
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Senior VP & Chief Science Officer 1962
Ms. Georgeann F. Couchara Senior Vice President of Human Resources 1977
Mr. Brian W. Ellis J.D. Executive Officer 1967
Mr. Christopher M. Bouda VP & Chief Accounting Officer NA
Dr. Martin Stumpe Ph.D. Chief Technology & AI Officer NA
Mr. John Bedford Vice President of Investor Relations NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 60.98M Dec 31, 2025 8.62% $0.20 0.14%
BlackRock Inc 52.30M Sep 30, 2025 7.40% $0.18 0.13%
JPMorgan Chase & Co 37.28M Sep 30, 2025 5.27% $0.22 404.67%
State Street Corp 27.21M Sep 30, 2025 3.85% $0.19 -0.33%
FMR Inc 19.51M Dec 31, 2025 2.76% $0.23 28.78%
Capital Research & Mgmt Co - Division 3 16.76M Sep 30, 2025 2.37% $0.54 1.90%
Wellington Management Company LLP 15.08M Dec 31, 2025 2.13% $0.60 11.19%
T. Rowe Price Associates, Inc. 14.64M Sep 30, 2025 2.07% $0.31 -11.90%
Geode Capital Management, LLC 13.85M Sep 30, 2025 1.96% $0.17 0.90%
Lombard Odier Asset Management (Europe) Ltd 13.51M Sep 30, 2025 1.91% $1.25 30,227.75%
Morgan Stanley - Brokerage Accounts 11.61M Sep 30, 2025 1.64% $0.14 2.40%
NORGES BANK 9.51M Dec 31, 2025 1.34% $0.23 -5.09%
Generation Investment Management LLP 7.59M Dec 31, 2025 1.07% $12.05 14.05%
Northern Trust Corp 7.41M Sep 30, 2025 1.05% $0.19 -1.62%
HHG PLC 6.91M Sep 30, 2025 0.98% $0.63 5.92%
Bank of America Corp 6.59M Sep 30, 2025 0.93% $0.09 8.46%
T. Rowe Price Investment Management,Inc. 6.57M Sep 30, 2025 0.93% $0.80 -5.45%
Eagle Capital Management LLC 6.16M Dec 31, 2025 0.87% $4.39 -0.35%
Bank of New York Mellon Corp 6.05M Sep 30, 2025 0.86% $0.22 -28.09%
Nuveen, LLC 5.60M Sep 30, 2025 0.79% $0.29 26.60%

Shares Statistics

▼
Shares Outstanding: 707.14M
Shares Float: 629.94M
% Insiders: 1,133.50%
% Institutions: 8,460.60%
Short % Float: 1.12%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Group Inc 60.98M 8.62% ▲ 0.14% Dec 31, 2025
2 BlackRock Inc 52.30M 7.40% ▲ 0.13% Sep 30, 2025
3 JPMorgan Chase & Co 37.28M 5.27% ▲ 404.67% Sep 30, 2025
4 State Street Corp 27.21M 3.85% ▼ 0.33% Sep 30, 2025
5 FMR Inc 19.51M 2.76% ▲ 28.78% Dec 31, 2025
6 Capital Research & Mgmt Co - Division 3 16.76M 2.37% ▲ 1.90% Sep 30, 2025
7 Wellington Management Company LLP 15.08M 2.13% ▲ 11.19% Dec 31, 2025
8 T. Rowe Price Associates, Inc. 14.64M 2.07% ▼ 11.90% Sep 30, 2025
9 Geode Capital Management, LLC 13.85M 1.96% ▲ 0.90% Sep 30, 2025
10 Lombard Odier Asset Management (Europe) Ltd 13.51M 1.91% ▲ 30,227.75% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $164.03B
Trailing P/E: 41.88
Forward P/E: 24.94

Financial Highlights

▼
Market Cap: $148.95B
EBITDA: $7.83B
P/E Ratio: $41.88
PEG Ratio: $1.90
Book Value: $74.32
Dividend/Share: $1.28
Dividend Yield: 0.61%
Earnings/Share: $5.03
Profit Margin: 14.71%
Operating Margin: 22.17%
ROA (TTM): 4.18%
ROE (TTM): 7.05%
Revenue (TTM): $24.57B
Revenue/Share (TTM): $34.47
Earnings Growth (YOY): 12.50%
Revenue Growth (YOY): 4.60%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.87x 0.35x 0.37x 19.38x 2.65x
2024-12-31 1.40x 0.33x 0.36x 18.65x 2.22x
2023-12-31 1.68x 0.35x 0.37x 18.19x 3.57x
2022-12-31 1.89x 0.40x 0.41x 36.41x 2.09x
2021-12-31 1.43x 0.50x 0.46x 33.40x 2.24x
2020-12-31 1.86x 0.54x 0.48x 15.79x 3.27x
2019-12-31 5.19x 0.72x 0.51x 30.96x 4.75x
2018-12-31 1.47x 0.35x 0.41x 22.43x 2.28x
2017-12-31 1.43x 0.40x 0.43x 19.36x 2.42x
2016-12-31 0.97x 0.53x 0.49x 16.20x 3.13x
2015-12-31 1.27x 0.54x 0.51x 17.29x 4.21x
2014-12-31 1.75x 0.15x 0.37x 29.36x 0.76x
2013-12-31 2.00x 0.16x 0.35x 23.08x 0.76x
2012-12-31 1.80x 0.28x 0.42x 20.29x 1.33x
2011-12-31 1.50x 0.31x 0.43x 19.33x 1.65x
2010-12-31 1.73x 0.21x 0.38x 18.49x 0.99x
2009-12-31 1.89x 0.25x 0.41x 14.13x 1.55x
2008-12-31 1.53x 0.27x 0.44x 14.99x 1.18x
2007-12-31 1.40x 0.41x 0.48x 15.74x 1.85x
2006-12-31 1.38x 0.37x 0.48x 18.87x 1.40x
2005-12-31 1.30x 0.21x 0.45x 28.36x 0.72x
2004-12-31 1.33x 0.29x 0.46x 19.95x 1.06x
2003-12-31 2.13x 0.36x 0.47x N/A 1.33x
2002-12-31 1.89x 0.44x 0.50x 16.06x 1.59x
2001-12-31 1.84x 0.53x 0.54x N/A 1.59x
2000-12-31 1.45x 0.41x 0.52x N/A 1.13x
1999-12-31 1.70x 0.02x 0.44x N/A 0.06x
1998-12-31 1.29x 0.04x 0.51x N/A 0.12x
1997-12-31 1.18x 0.04x 0.51x N/A 0.10x
1996-12-31 1.15x 0.02x 0.55x N/A 0.06x
1995-12-31 1.15x 0.03x 0.61x N/A 0.06x
1994-12-31 0.98x 0.14x 0.58x N/A 0.36x
1993-12-31 1.18x 0.01x 0.58x N/A 0.02x
1992-12-31 1.08x 0.09x 0.55x N/A 0.32x
1991-12-31 1.24x 0.01x 0.57x N/A 0.03x
1990-12-31 1.31x 0.00x 0.59x N/A 0.01x
1989-12-31 1.17x 0.00x 0.62x N/A 0.01x
1988-12-31 1.47x 0.01x 0.73x N/A 0.02x
1987-12-31 2.03x 0.01x 0.84x N/A 0.02x
1986-12-31 1.46x 1.40x 0.91x N/A 2.16x
1985-12-31 3.54x 0.05x 0.81x N/A 0.09x

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 19, 2026 Gregory M Milosevich N/A Sale 1.32K $208.01 $274.57K
Jan 29, 2026 Ro Khanna N/A Sale N/A $219.62 N/A
Dec 18, 2025 Julie Johnson N/A Sale N/A $224.43 N/A
Nov 18, 2025 Teri List N/A Sale 3.30K $226.50 $747.00K
Nov 13, 2025 Julie Johnson N/A Sale N/A $221.50 N/A
Nov 12, 2025 Brian W Ellis N/A Sale 21.78K $219.23 $4.77M
Nov 10, 2025 Georgeann Couchara N/A Sale 5.17K $210.42 $1.09M
Nov 07, 2025 Ro Khanna N/A Sale N/A $209.89 N/A
Nov 03, 2025 Ro Khanna N/A Purchase N/A $214.10 N/A
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $221.20 N/A
Oct 07, 2025 Julie Johnson N/A Purchase N/A $208.63 N/A
Oct 03, 2025 Ro Khanna N/A Purchase N/A $215.05 N/A
Sep 29, 2025 Ro Khanna N/A Sale N/A $185.87 N/A
Sep 25, 2025 Lisa C. McClain N/A Sale N/A $181.56 N/A
Sep 25, 2025 Michael T. McCaul N/A Purchase N/A $181.56 N/A
Sep 09, 2025 Michael T. McCaul N/A Purchase N/A $194.24 N/A
Sep 05, 2025 Ro Khanna N/A Purchase N/A $200.32 N/A
Sep 03, 2025 Thomas H. Kean, Jr. N/A Purchase N/A $199.40 N/A
Aug 28, 2025 Sheldon Whitehouse N/A Sale N/A $205.42 N/A
Aug 22, 2025 Teri List N/A Sale 2.78K $211.06 $586.32K

📦 Raw API Data (JSON Explorer)

▼

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DHR.US!